BioWorld - Monday, March 16, 2026

Analysis and data insight
Analysis and data insight RSS Feed RSS

Other financings of public biotechnology companies in March 2020

April 3, 2020
Private placements and other private financings of public biopharma companies, including: AB Science, Akari, Armata, Aytu, Baudax, Bellerophon, Biocurepharm, Brainstorm, Bridgebio, Cocrystal, Cytodyn, Emmaus Life Sciences, Enlivex, Equillium, Ethismos Research, Eton, Eyenovia, Helix, Hemostemix, IMV, Isofol Medical, Lattice, Marker, Moberg, Novan, Oncology Venture, Oncoquest, Pacylex, Plx, Predictive Oncology, Propanc, Protalix, Redx, Rockwell Medical, Theravance, Titan, Tonix, Unum, Vaccinex, Vaxart, Vaxil Bio, Verastem, Verrica, Vistagen, Xortx, Zosano.
Read More
Handshake, businessmen holding dollar sign, lightbulb

Med-tech deal and M&A values drop in Q1, significantly down from last year

April 3, 2020
By Karen Carey
A flurry of deal and M&A activity in the med-tech industry during the first quarter of 2020 has not translated into high financials, as many of the transactions are not disclosing terms. While the COVID-19 pandemic rages on, business development activities appear to be slumping in recent weeks, leaving the early part of the year significantly down from prior quarters.
Read More

Venture capital and other private biopharma financings in March 2020

April 3, 2020
Venture capital and other private financings of private biopharma companies, including: Abbisko, Advanced Biodesign, Affinia, Akouos, AM-Pharma, Amunix, Apexigen, Biosight, Castle Creek, Cinclus, Circle, Clarus, Design, Elevatebio, Eureka, Evonetix, Exuma, Harbour Biomed, Immunocore, Kallyope, Keros, Kymera, Lipidio, Nanjing Iaso, Numab, Nurix, Oncoone R&D, Onethree, Pliant, Polyprox, Primmune, Recode, Redpin, Regenacy, Sigilon, Silverback, Sutrovax, Svenska Vaccinfabriken Produktion, Syndivia, Tikomed, Xilio, Zucara.
Read More